(0.81%) 5 059.13 points
(0.77%) 38 194 points
(1.36%) 15 817 points
(0.08%) $79.06
(4.92%) $2.03
(0.26%) $2 317.10
(0.61%) $26.91
(1.09%) $965.35
(-0.05%) $0.933
(-0.35%) $10.99
(-0.03%) $0.798
(-1.36%) $91.99
5 days till quarter result
(bmo 2024-05-07)
Expected move: +/- 9.10%
@ $163.48
Išleistas: 2 geg. 2024 @ 20:02
Grąža: 0.16%
Ankstesnis signalas: geg. 1 - 22:37
Ankstesnis signalas:
Grąža: 2.32 %
Live Chart Being Loaded With Signals
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally...
Stats | |
---|---|
Šios dienos apimtis | 425 905 |
Vidutinė apimtis | 491 549 |
Rinkos kapitalizacija | 9.13B |
EPS | $0.330 ( 2024-05-01 ) |
Kita pelno data | ( $0.290 ) 2024-05-07 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 221.26 |
ATR14 | $8.32 (5.08%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-02 | Bylund James | Sell | 444 | Common Stock |
2024-03-18 | Hunt Anthony | Sell | 2 000 | Common Stock |
2024-03-18 | Pax Margaret | Buy | 2 236 | Stock Option (Right to Buy) |
2024-03-18 | Pax Margaret | Buy | 195 | Stock Option (Right to Buy) |
2024-03-18 | Pax Margaret | Buy | 92 | Common Stock |
INSIDER POWER |
---|
50.60 |
Last 95 transactions |
Buy: 209 116 | Sell: 60 033 |
Tūris Koreliacija
Repligen Corp Koreliacija
10 Labiausiai teigiamai susiję koreliacijos |
---|
10 Labiausiai neigiamai susiję koreliacijos |
---|
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Repligen Corp Koreliacija - Valiuta/Žaliavos
Repligen Corp Finansinės ataskaitos
Annual | 2023 |
Pajamos: | $638.76M |
Bruto pelnas: | $284.25M (44.50 %) |
EPS: | $0.750 |
FY | 2023 |
Pajamos: | $638.76M |
Bruto pelnas: | $284.25M (44.50 %) |
EPS: | $0.750 |
FY | 2022 |
Pajamos: | $801.54M |
Bruto pelnas: | $455.71M (56.85 %) |
EPS: | $3.35 |
FY | 2021 |
Pajamos: | $670.53M |
Bruto pelnas: | $391.25M (58.35 %) |
EPS: | $2.33 |
Financial Reports:
No articles found.
Repligen Corp
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes. It also offers ELISA test kits; and chromatography resins under the CaptivA brand. In addition, the company provides filtration products, such as XCell Alternating Tangential Flow systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; Spectra/Por laboratory and process dialysis products, and SpectraFlo dynamic dialysis systems; and ProConnex single-use hollow fiber. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has collaboration agreements with Navigo Proteins GmbH to develop multiple affinity ligands. Repligen Corporation was incorporated in 1981 and is headquartered in Waltham, Massachusetts.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.